MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rafestin-Oblin, M.-E.
Right arrow Articles by Vandewalle, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rafestin-Oblin, M.-E.
Right arrow Articles by Vandewalle, A.

Vol. 62, Issue 6, 1306-1313, December 2002

11beta -Hydroxyprogesterone Acts as a Mineralocorticoid Agonist in Stimulating Na+ Absorption in Mammalian Principal Cortical Collecting Duct Cells

Marie-Edith Rafestin-Oblin, Jerome Fagart, Anny Souque, Cendrine Seguin, Marcelle Bens, and Alain Vandewalle

Institut National de la Santé et de la Recherche Médicale U478, Institut Fédératif de Recherche 02, Faculté de Médecine Xavier Bichat, Paris, France

The binding of mineralocorticoid hormones to the mineralocorticoid receptor is the first step in a cascade of events leading to the stimulation of Na+ reabsorption by renal cortical collecting duct (CCD) principal cells. The agonist properties of mineralocorticoid hormones are linked to contacts between their 21-hydroxyl group and Asn770, a residue of the ligand-binding domain of the human mineralocorticoid receptor (hMR). Here, we investigate whether the presence of a hydroxyl group at position 11, 17, or 20 could also alter the activity of progesterone (P), a mineralocorticoid antagonist without the 21-hydroxyl group. Both 17alpha -hydroxyprogesterone (17OHP) and 20alpha -hydroxyprogesterone (20OHP) antagonized the aldosterone-induced trans-activation activity (IC50: 17OHP, 10-7 M; 20OHP, 10-8 M) of the hMR transiently expressed in COS-7 cells lacking steroid receptors. In cultured mouse mpkCCDcl4 principal cells, 17OHP and 20OHP also prevented the aldosterone-stimulated amiloride-sensitive component of the short-circuit current (Ams Isc), reflecting Na+ absorption mediated by the epithelial Na+ channel (ENaC). In contrast, 11beta -hydroxyprogesterone (11OHP) activated the transiently expressed hMR in COS-7 cells in a dose-dependent manner (ED50: 10-8 M) and, like aldosterone, stimulated Ams Isc in mpkCCDcl4 cells. Docking 11OHP within the hMR-ligand-binding domain homology model revealed that the agonist activity of 11OHP is caused by contacts between its 11beta -hydroxyl group and Asn770. Furthermore, 11OHP was unable to activate the mutant hMR/N770A, in which Ala is substituted for Asn at position 770. These findings demonstrate that in the absence of the 21-hydroxyl group, the 11beta -hydroxyl group can produce the contact with the hMR-Asn770 required for the hMR activation leading to stimulated Na+ absorption.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
V. Leroy, S. De Seigneux, V. Agassiz, U. Hasler, M.-E. Rafestin-Oblin, M. Vinciguerra, P.-Y. Martin, and E. Feraille
Aldosterone Activates NF-{kappa}B in the Collecting Duct
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 131 - 144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Huyet, G. M. Pinon, M. R. Fay, J. Fagart, and M.-E. Rafestin-Oblin
Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor
Mol. Pharmacol., September 1, 2007; 72(3): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A.-N. Takeda, G. M. Pinon, M. Bens, J. Fagart, M.-E. Rafestin-Oblin, and A. Vandewalle
The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor
Mol. Pharmacol., February 1, 2007; 71(2): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Groyer, B. Eychenne, C. Girard, K. Rajkowski, M. Schumacher, and F. Cadepond
Expression and Functional State of the Corticosteroid Receptors and 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Schwann Cells
Endocrinology, September 1, 2006; 147(9): 4339 - 4350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Bledsoe, K. P. Madauss, J. A. Holt, C. J. Apolito, M. H. Lambert, K. H. Pearce, T. B. Stanley, E. L. Stewart, R. P. Trump, T. M. Willson, et al.
A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor
J. Biol. Chem., September 2, 2005; 280(35): 31283 - 31293.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Naray-Fejes-Toth, P. M. Snyder, and G. Fejes-Toth
The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport
PNAS, December 14, 2004; 101(50): 17434 - 17439.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics